Clinical Trial Update: Gardasil Immunogenicity With Needle-Free Injection [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating immunogenicity of Gardasil delivered by a needle-free injection in HIV-related conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Thai Red Cross AIDS Research Centre | Conditions: HIV | Phase 2 | Status: COMPLETED